NCT02352701View on ClinicalTrials.gov

Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori

CompletedOBSERVATIONAL

Enrollment

320

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Helicobacter Infections

Interventions

DRUG

Noltec tab. 10mg

Ilaprazole 10mg BID dosage form : delayed release tablet

DRUG

Chongkundang Amoxicillin Cap. 500mg

Amoxicillin 1000mg, BID dosage form : capsule

DRUG

Cravit Tab. 500mg

Levofloxacin 500mg, BID dosage form : film coated tablet

Trial Locations (1)

Unknown

The Catholic Univ. of Korea Daejeon St.Mary Hospital, Daejeon

All Listed Sponsors

lead

Il-Yang Pharm. Co., Ltd.

INDUSTRY

NCT02352701 - Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori | Biotech Hunter | Biotech Hunter